Veterinary Health Research Centers Finalist for Citeline’s Most Innovative Start-up Company Award
RICHMOND, Va. – March 3, 2023 – PRLog — Pharma, healthcare and biotech researchers constantly face pressure to keep up in a fast-paced and ever-evolving industry. The need to conduct high-risk clinical trials that require significant resources can make it even more challenging for small companies with limited financial and human resources to make go/no-go decisions. By identifying animals with spontaneous conditions, VHRC can expedite clinical trial enrollment for new technologies, products, medications, therapies, and devices for both humans and animals.
“We are encouraged that Citeline Awards 2023 has chosen us as a finalist for the Most Innovative Start-up Company category,” said VHRC founder Dr. Joel Ehrenzweig. “Our journey began with an aim of improving the lives of animals with veterinary practices hosting clinical trials for patients with naturally occurring conditions, including cancer, cognitive decline, inflammation and immune-mediated, and low-incidence (MUMS) diseases.”
VHRC co-founder Dr. Rob Hunter continued, “People and pets share many of the same conditions, so when a study finds a successful animal treatment, that data can have One Health translational value and will be very supportive in regulatory submissions for products treating people with the same condition.”
The mission of VHRC has garnered support from prospective beneficiaries–both in research and in practice-because benefits accrue to sponsors, veterinarians, and caregivers, all of whom are seeking viable treatment options for their pets. This win-win-win design has enabled it to make a significant impact on the biotech industry, as evidenced by the Citeline Innovation Award recognition. The winners will be announced at the Awards ceremony on Thursday, 27 April at the Westin Boston Seaport District Hotel.
About Veterinary Health Research Centers LLC (VHRC)
VHRC specializes in developing and conducting small-scale POC, pre-IND and pre-INAD studies for pharmaceutical companies, biopharma, medical device, and life science innovators. It is headquartered in the Kansas City Animal Health Corridor (Overland Park, KS), with offices in Richmond, Virginia. For more information about VHRC innovative services, visit http://www.VHRCenters.com; email: firstname.lastname@example.org; or call +1-804-735-8205.
Citeline (formerly Pharma Intelligence) powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory related-decisions and create real-world opportunities for growth.
Global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world’s most trusted life science partners, visit Citeline
Tennis Innovators Academy (TIA) is proud to sponsor Christopher Bulus, a promising tennis player, with year-round training to compete on the ATP Tour full-time. In addition to a tennis training regimen, the sponsorship includes comprehensive fitness and healthcare coverage as well as competition provided by HEAD, a prominent tennis brand. Cesar Andrade, TIA Director of Operations and Vladimir Margalitadze, Director of Tennis at TIA, will be his managers and head coaches.
“We are thrilled to support Chris in his endeavors on the professional tennis circuit and hope this serves as a symbol of courage to other talented, young athletes,” said Cesar. “The lifespan of a professional tennis player has increased over the years, therefore, giving college graduates a chance to pursue their dreams in professional tennis, which was not even a thought 15 years ago.”
About Christopher Bulus
A Nigerian native, Bulus started his tennis career in Lagos, Nigeria. He trained at the Lagos Lawn Tennis Club under Abel Ubiebi. In 2017, Chris was rated as high as No. 6 in Nigeria and by 2018 he ranked No. 328 in ITF world rankings. In addition to his high-profile junior resume, he represented Nigeria at the Junior Davis Cup in 2016 and the All-African Youth Games in 2018. Amongst being a finalist in several ITF events, he won his first ITF title at Grade 5 in Lomé, Togo in 2017. These accomplishments afforded Chris the opportunity to play for a college in the United States.
Bulus attended the New Mexico Military Institute, for the first two years, where he earned his associates degree. Chris won the Region V championship and All-American singles titles in 2018 and 2019. He transferred to the University of West Alabama (UWA) where he earned the ITA Division II All-American Singles title in 2021. He also won ITA summer circuit title in Corpus Christi, Texas, in 2020. Chris finished the 2021 season ranked No. 4 in the Division II national rankings while at UWA.
For his senior year, Bulus was recruited to join the men’s team at the University of Nevada, Las Vegas (UNLV) where he achieved No. 31 in Division I national rankings in February 2022. He represented UNLV at No. 1 singles position and made his debut appearance at the NCAA Individual National Championships in May 2022. While at UNLV, Chris developed a friendship with a tennis legend Andre Agassi. “Andre’s support has been meaningful in this process,” said Chris.
After receiving an undergraduate degree in economics from UNLV earlier this year, Bulus permanently moved to White Plains, NY in the summer to begin his training at Tennis Innovators Academy. Since joining TIA, Bulus already had several notable accomplishments. He won the qualifying draw at the M15 ITF event in Memphis, TN and made it to the finals of two UTR PPT events, $10K money tournament in Boca Raton, FL as well as a $25K event in South Orange, NJ.
“I am so thankful to TIA for this once-in-a-lifetime opportunity. It is a very special moment for me and I’m very excited for the journey ahead and will keep working towards my goals while enjoying the process,” said Bulus.